'JSLL: Jeena Sikho Lifecare Limited has informed the Exchange about the publication of research papers'.
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jeena Sikho Lifecare Limited informed the stock exchange that two research articles authored by its medical team, including Managing Director Acharya Manish Grover, have been published in peer-reviewed journals. The first article, published in the International Journal of AYUSH (June 2025), presents a case study where a 39-year-old asymptomatic diabetic patient at the company's Karol Bagh clinic saw his HbA1c drop from 9.8% to 5.64% within a month of Ayurvedic treatment. The second article, published in the International Journal of Advanced Research (June 2025), documents a 45-year-old patient at the company's Navi Mumbai hospital whose HbA1c fell from 10.4% to 4.9% in roughly 74 days using a combination of Panchakarma therapy, oral Ayurvedic medicines, and a structured diet plan. The filings are part of the company's ongoing efforts to build evidence-based credibility for its Ayurvedic treatment offerings, particularly in diabetes management.
This is a routine research publication disclosure with no direct impact on revenue, orders, or financials. It may serve as soft brand-building and marketing material for the company's Ayurvedic diabetes treatment services, potentially supporting patient acquisition, but does not change the fundamental outlook for shareholders.